- Home
- BIO vs CHRD Comparison
BIO vs CHRD Comparison
Compare BIO & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- CHRD
- Stock Information
- Founded
- BIO 1952
- CHRD 2007
- Country
- BIO United States
- CHRD United States
- Employees
- BIO N/A
- CHRD N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- CHRD Oil & Gas Production
- Sector
- BIO Industrials
- CHRD Energy
- Exchange
- BIO Nasdaq
- CHRD Nasdaq
- Market Cap
- BIO 6.0B
- CHRD 5.9B
- IPO Year
- BIO N/A
- CHRD 2010
- Fundamental
- Price
- BIO $246.53
- CHRD $106.40
- Analyst Decision
- BIO Strong Buy
- CHRD Buy
- Analyst Count
- BIO 4
- CHRD 12
- Target Price
- BIO $324.25
- CHRD $151.25
- AVG Volume (30 Days)
- BIO 314.0K
- CHRD 770.3K
- Earning Date
- BIO 07-31-2025
- CHRD 08-06-2025
- Dividend Yield
- BIO N/A
- CHRD 6.27%
- EPS Growth
- BIO N/A
- CHRD N/A
- EPS
- BIO N/A
- CHRD 15.19
- Revenue
- BIO $2,541,100,000.00
- CHRD $5,036,741,000.00
- Revenue This Year
- BIO N/A
- CHRD N/A
- Revenue Next Year
- BIO $3.42
- CHRD N/A
- P/E Ratio
- BIO N/A
- CHRD $7.00
- Revenue Growth
- BIO N/A
- CHRD 31.78
- 52 Week Low
- BIO $211.43
- CHRD $79.83
- 52 Week High
- BIO $387.99
- CHRD $177.95
- Technical
- Relative Strength Index (RSI)
- BIO 52.25
- CHRD 56.94
- Support Level
- BIO $244.45
- CHRD $102.00
- Resistance Level
- BIO $264.68
- CHRD $109.64
- Average True Range (ATR)
- BIO 6.91
- CHRD 3.37
- MACD
- BIO -0.61
- CHRD -0.14
- Stochastic Oscillator
- BIO 30.57
- CHRD 75.80
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.